perindopril has been researched along with Cirrhosis, Liver in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Rahman, SS; Fayed, HM | 1 |
| Groothuis, GM; Olinga, P; Oosterhuis, D; Westra, IM | 1 |
| Aihara, Y; Douhara, A; Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Mitoro, A; Morioka, C; Noguchi, R; Sawai, M; Toyohara, M; Uemura, M; Yamao, J; Yoshida, M; Yoshiji, H | 1 |
| Fukui, H; Noguchi, R; Yoshiji, H | 1 |
| Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Kitade, M; Kojima, H; Mitoro, A; Noguchi, R; Toyohara, M; Uemura, M; Yamao, J; Yamazaki, M; Yoshiji, H | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Fukui, H; Ikenaka, Y; Imazu, H; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Funck-Brentano, C; Grangé, JD; Jaillon, P; Midavaine, M; Resplandy, G; Thiollet, M | 1 |
| Hughes, DM; Lees, KR; McNeill, CA; Reid, JL | 2 |
| Howden, CW; Lees, KR; Reid, JL; Tsai, HH | 1 |
4 trial(s) available for perindopril and Cirrhosis, Liver
| Article | Year |
|---|---|
Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.
Topics: Amino Acids, Branched-Chain; Angiotensin-Converting Enzyme Inhibitors; Collagen Type IV; Drug Therapy, Combination; Female; Humans; Hyaluronic Acid; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Perindopril; Transforming Growth Factor beta; Treatment Outcome | 2012 |
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Disease Progression; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Perindopril; Transforming Growth Factor beta | 2006 |
Pharmacokinetics of perindopril: therapeutic consequences.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Indoles; Liver Cirrhosis; Male; Middle Aged; Perindopril; Random Allocation | 1989 |
The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
Topics: Administration, Oral; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Blood Pressure; Female; Humans; Indoles; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Renin | 1989 |
7 other study(ies) available for perindopril and Cirrhosis, Liver
| Article | Year |
|---|---|
Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat.
Topics: Angiotensin II; Animals; Liver Cirrhosis; Male; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Thioacetamide | 2019 |
Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.
Topics: Animals; Becaplermin; Benzamides; Benzylisoquinolines; Cinnamates; Collagen Type I; Connective Tissue Growth Factor; Depsides; Down-Regulation; Gene Expression; HSP47 Heat-Shock Proteins; Imatinib Mesylate; Liver; Liver Cirrhosis; Male; Models, Biological; Niacinamide; Organ Culture Techniques; Perindopril; Phenylurea Compounds; Piperazines; Proto-Oncogene Proteins c-sis; Pyridones; Pyrimidines; Rats; Rats, Wistar; Rosmarinic Acid; Sorafenib; Transforming Growth Factor beta1; Valproic Acid | 2014 |
Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.
Topics: Alanine Transaminase; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Perindopril; RNA, Viral | 2005 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.
Topics: Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Animals; Choline; Diethylnitrosamine; Disease Models, Animal; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Perindopril; Precancerous Conditions; Rats; Rats, Inbred F344; Renin-Angiotensin System | 2002 |
The pharmacokinetics of perindopril in patients with liver cirrhosis.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Indoles; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Perindopril | 1992 |
Pharmacokinetics of perindopril: therapeutic consequences.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Evaluation; Half-Life; Humans; Hypertension; Indoles; Liver Cirrhosis; Male; Middle Aged; Perindopril; Random Allocation | 1989 |